VYNE Therapeutics Earnings Surprises image   This VYNE earnings surprises page last updated 8/27/2025
VYNE Therapeutics Earnings Surprises Chart
PeriodExpectedActualSurprise
Q2 2025 -0.09 -0.13 -0.04 (+44%)
Q1 2025 -0.29 -0.20 +0.09 (-31%)
Q4 2024 -0.31 -0.28 +0.03 (-10%)
Q3 2024 -0.23 -0.29 -0.06 (+26%)
Q2 2024 -0.19 -0.22 -0.03 (+16%)
Q1 2024 -0.24 -0.15 +0.09 (-38%)
Q4 2023 -0.50 -0.18 +0.32 (-64%)
Q2 2023 -1.99 -2.82 -0.83 (+42%)
Q4 2022 -3.24 -2.97 +0.27 (-8%)
Q3 2022 -3.06 -2.52 +0.54 (-18%)
Q2 2022 -3.06 -2.34 +0.72 (-24%)
Q1 2022 -2.88 1.80 +4.68 (-162%)
Q4 2021 -4.32 -3.60 +0.72 (-17%)
Q3 2021 -5.76 -6.48 -0.72 (+13%)
Q1 2021 -7.38 -6.66 +0.72 (-10%)
Q4 2020 -9.54 -7.74 +1.80 (-19%)
Q3 2020 -12.24 -9.36 +2.88 (-24%)
Q2 2020 -1.00 -3.28 -2.28 (+228%)
Q1 2020 -2.16 -3.80 -1.64 (+76%)
VYNE Therapeutics Revenue Surprises Chart
PeriodExpectedActualSurprise
Q2 2025 130000 69000 -61000 (-47%)
Q1 2025 50000 202000 +152000 (+304%)
Q4 2024 180000 84000 -96000 (-53%)
Q3 2024 110000 121000 +11000 (+10%)
Q2 2024 110000 198000 +88000 (+80%)
Q1 2024 100000 98000 -2000 (-2%)
Q4 2023 150000 76000 -74000 (-49%)
Q2 2023 100000 135000 +35000 (+35%)
Q4 2022 60000 6000 -54000 (-90%)
Q3 2022 130000 167000 +37000 (+28%)
Q2 2022 100000 126000 +26000 (+26%)
Q1 2022 370000 178000 -0.19M (-52%)
Q4 2021 4.12M 2.29M -1.83M (-44%)
Q3 2021 4.76M 4.09M -0.67M (-14%)
Q1 2021 5.31M 4.12M -1.19M (-22%)
Q4 2020 4.71M 4.29M -0.42M (-9%)
Q3 2020 3.25M 3.27M +19000 (+1%)
Q2 2020 2.42M 11.69M +9.27M (+383%)
Q1 2020 2.18M 1.75M -0.43M (-20%)
Quotes delayed 20 minutes

Email EnvelopeFree VYNE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options

Next Earnings Date Calendar:

Donaldson (DCI): 8/27/2025 6:00 AM
Photronics (PLAB): 8/27/2025 6:30 AM
JM Smucker (SJM): 8/27/2025 7:00 AM
Kohl's (KSS): 8/27/2025 7:00 AM
Destination XL Group (DXLG): 8/27/2025 7:00 AM
Abercrombie & Fitch (ANF): 8/27/2025 7:30 AM
REX American Resources (REX): 8/27/2025 7:30 AM
MasterCraft Boat Hldgs (MCFT): 8/27/2025 7:30 AM
Williams-Sonoma (WSM): 8/27/2025 8:00 AM
Applied Digital (APLD): 8/27/2025 After close

More from the Next Earnings Dates Calendar

Earnings History:

Metsera (MTSR): 8/26/2025 5:00 PM
Immix Biopharma (IMMX): 8/26/2025 5:00 PM
Actinium Pharmaceuticals (ATNM): 8/26/2025 5:00 PM
BankFinancial (BFIN): 8/26/2025 5:00 PM
Ooma (OOMA): 8/26/2025 After close
PVH (PVH): 8/26/2025 After close
Electromed (ELMD): 8/26/2025 After close
Trump Media & Technology (DJT): 8/26/2025 After close
Ncino (NCNO): 8/26/2025 After close
Box (BOX): 8/26/2025 After close

More from the Earnings History archive
VYNE Therapeutics (VYNE) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

VYNT Historical Earnings
WAT Historical Earnings
WGS Historical Earnings
WHWK Historical Earnings
WINT Historical Earnings
WST Historical Earnings
XAIR Historical Earnings
XBIO Historical Earnings
XCUR Historical Earnings
XENT Historical Earnings
On this page we presented the VYNE earnings surprises information for VYNE Therapeutics, comparing the expected earnings versus the actual earnings quarter by quarter, with the resulting positive or negative percentage surprise. Any self directed investor doing their due diligence on VYNE (or any other given stock) can benefit from researching all of the VYNE Therapeutics past earnings going backwards in time, including how often the company beat or missed the market's expectations. To help you with this VYNE Therapeutics earnings surprise research, on this page we presented each quarter's resulting numbers for easy comparison. Studying these numbers can help an investor by providing important context with which to think about VYNE's next earnings report. In your continued research on VYNE Therapeutics we hope you will be sure to check out the further links included for revenue and earnings history as well as next earnings dates for VYNE. Thanks for visiting, and the next time you need to research VYNE earnings surprises or those of another stock, we hope you'll think of our site as your go-to earnings surprises research resource of choice.

Recommended: Institutional Holders of JJMB, FOCS Insider Buying, ALDW Historical Stock Prices.

 

VYNE Therapeutics Earnings Surprises | www.NextEarningsDate.com | Copyright © 2020 - 2025, All Rights Reserved

Nothing in NextEarningsDate.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.